复方樟柳碱穴位注射治疗脑梗死引起眼外肌麻痹的临床疗效及对患者眼外肌功能的影响

Clinical efficacy of compound anisodine acupoint injection in treating extraocular muscle paralysis caused by cerebral infarction and its influence on the function of extraocular muscle

目的探究复方樟柳碱穴位注射治疗脑梗死引起眼外肌麻痹的临床疗效及对患者眼外肌功能的影响。方法选取2018年1月至2021年1月于本院接受治疗的68例脑梗死引起眼外肌麻痹患者作为研究对象,按照随机数字表法分为对照组与实验组,各34例。对照组采取常规西药治疗,实验组采取复方樟柳碱颞浅动脉旁皮下注射治疗,比较两组眼外肌功能改善情况及临床疗效。结果实验组治疗总有效率为97.06%,高于对照组的76.47%,差异有统计学意义(P<0.05);实验组眼外肌限制发生率为11.76%,低于对照组的47.06%,差异有统计学意义(P<0.05);实验组眼外肌麻痹发生率为14.71%,低于对照组的50.00%,差异有统计学意义(P<0.05)。结论复方樟柳碱穴位注射治疗脑梗死引起眼外肌麻痹患者疗效显著,可加快患者眼外肌功能恢复,值得临床推广应用。

Objective To investigate the clinical efficacy of compound anisodine acupoint injection in treating extraocular muscle paralysis caused by cerebral infarction and its influence on the function of extraocular muscle.Methods 68 patients with extraocular muscle paralysis caused by cerebral infarction treated in our hospital from January 2018 to January 2021 were selected as the study subjects,and they were divided into the control group and the experimental group according to random number table method,with 34 cases in each group.The control group was treated with conventional Western medicine,and the experimental group was treated with compound anisodine subcutaneous injection near the superficial tempo-ral artery.The improvement of extraocular muscle function and the clinical efficacy were compared between the two groups.Results The total effec-tive rate in the experimental group was 97.06%,which was higher than 76.47%in the control group,the difference was statistically significant(P<0.05).The incidence of extraocular muscle restriction in the experimental group was 11.76%,which was lower than 47.06%in the control group,and the difference was statistically significant(P<0.05).The incidence of extraocular muscle paralysis in the experimental group was 14.71%,which was lower than 50.00%in the control group,and the difference was statistically significant(P<0.05).Conclusion Acupoint injection of compound anisodine is effective in the treatment of patients with extraocular muscle paralysis caused by cerebral infarction,which can accelerate the recovery of extraocular muscle function and is worthy of clinical promotion and application.